SCHEMBL4451690

SCHEMBL4451690

CC1=C(CCCC(=O)NCCN)C(=O)c2ccccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
LMNA P02545 3/20 0.44
PKM P14618 2/20 0.44
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HTT P42858 2/20 0.44
APAF1 O14727 1/20 0.44
MITF O75030 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
HPGD P15428 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HDAC3 O15379 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25753887 0.88 HDAC2 (0.49) HDAC2HDAC6LMNAPKMALDH1A1
SCHEMBL21940137 0.87 HDAC2 (0.51) HDAC2HDAC6LMNAPKMALDH1A1
SCHEMBL25753979 0.84 ALDH1A1 (0.47) HDAC2HDAC6LMNAALDH1A1L3MBTL1
SCHEMBL25753852 0.83 LMNA (0.48) HDAC2HDAC6LMNAPKMALDH1A1
SCHEMBL21878898 0.83 TRPV1 (0.50) HDAC2HDAC6LMNAPKMALDH1A1
SCHEMBL13649309 0.81 MAPT (0.48) HDAC2HDAC6LMNAPKMALDH1A1
SCHEMBL25753851 0.81 RECQL (0.49) HDAC2HDAC6LMNAPKMALDH1A1
Hydrochloric Acid SCHEMBL4115438 0.80 MAPT (0.47) HDAC2HDAC6LMNAPKMALDH1A1
SCHEMBL21939615 0.80 F13A1 (0.49) HDAC2HDAC6ALDH1A1NPC1RAB9A
SCHEMBL21939844 0.79 F13A1 (0.51) HDAC2HDAC6ALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544438-B2 Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode DAIICHI PURE CHEMICALS CO., LTD (JP) 2009-06-09 US claimed
US-20050049313-A1 Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode DAIICHI PURE CHEMICALS CO., LTD. 2005-03-03 US claimed
US-7544438-B2 Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode DAIICHI PURE CHEMICALS CO., LTD (JP) 2009-06-09 US disclosed
US-7544438-B2 Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode DAIICHI PURE CHEMICALS CO., LTD (JP) 2009-06-09 US disclosed
US-7544438-B2 Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode DAIICHI PURE CHEMICALS CO., LTD (JP) 2009-06-09 US disclosed
US-20050049313-A1 Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode DAIICHI PURE CHEMICALS CO., LTD. 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050049313-A1 Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode SQOR, ME3, VAT1 HDAC2 3733/4885HDAC6 4144/4885LMNA 3631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.